Join leading experts to discuss how we are ushering in a new era in bladder cancer care on May 28 virtually. Register now.

Bladder cancer is among the top 10 most common cancer types in the world, with approximately 573,000 new cases annually. Men ...

UroGen Pharma ( NASDAQ: URGN) announced on Wednesday that the U.S. FDA has scheduled an Oncologic Drugs Advisory Committee ...

Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment ...

Congressman Greg Murphy, M.D., is recognizing May as Bladder Cancer Awareness Month. “While most bladder cancers are caught ...

John Daly shared a grim health update on Tuesday, May 6 after the golfer withdrew from the PGA Championship, sharing that ...

ImmunityBio's ANKTIVA sBLA for papillary bladder cancer was rejected by the FDA despite prior support, prompting the company ...

CG Oncology Inc.’s latest research effort to treat bladder cancer is impressing investors.The Irvine-based biopharmaceutical ...

Though the connection seems unusual, this news could change the lives of more than 700,000 Americans living with this disease ...

Research and development expenses for the first quarter of 2025 increased to $9.1 million from $7.7 million for the prior ...

Neal Shore, MD, FACS, discusses sasanlimab and its potential impact for community oncologists when treating patients with ...